Aimmune Therapeutics
— PALISADE Top-Line Results Expected in 4Q 2017 —
- Form
- 8-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001564590-16-025333
- Document
- 8-K
- Exhibit 99.1
- Press release
- Makes a Regulation FD disclosure (7.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
